sarscov2

Zydus seeks DCGI nod for clinical trial for monoclonal antibodies cocktail

Zydus has announced biological therapy ZRC-3308, used to treat mild COVID-19. The pharmaceutical company now seeks DCGI (Drugs Controller General…

3 years ago

NCDC director says UK variant may be the cause of second wave

National Centre for Disease Control (NCDC) director, Sujeet Singh on Friday stated that the current wave of the coronavirus pandemic…

4 years ago

COVAXIN shows 100% efficacy against COVID-19

COVAXIN shows 78% clinical and 100% efficacy against severe COVID-19 The COVAXIN developed and manufactured by Bharat Biotech, “neutralizes multiple…

4 years ago

Three Common Antiviral Drugs Potentially Effective Against COVID-19

A team of researchers has found that three commonly used antiviral and antimalarial drugs are effective at preventing reproduction of…

4 years ago

Maha reports Daily surge above 28,000

Five States of Maharashtra, Punjab, Karnataka, Chhattisgarh and Gujarat are reporting a surge in the COVID daily new cases. These…

4 years ago

Sequencing in Sars-Cov2 may help monitor evolution of mutants: Study

The last month of the year 2020 began with worrying news regarding new variants of SARS-CoV-2 that show increased transmissibility,…

4 years ago

Study: RNA analysis shows most SARS-Cov2 variants rarely persist through secondary transmission

A large team of researchers affiliated with a host of institutions across the U.K. has found that most SARS-CoV-2 variants…

4 years ago

Covid Diagnosis now on your phone

According to the engineers of Rice University, Covid-19 can now be detected in 55 minutes or less with the help…

4 years ago